Skip to evidence report

HPC.MPP_activated: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 227 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for HPC.MPP_activated
#Trait / studyIndividual trait IDMean IC score
1SDC4 levelsGCST90470559106.32
2Mosaic chromosomal alteration of the Y chromosomeGCST90165289103.26
3EDAR levelsGCST9046906899.82
4mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047545095.35
5mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544692.72
6Mean corpuscular haemoglobin | Blood countUKBB0000044789.41
7mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST9047544286.71
8CCN2 levelsGCST9046858885.97
9HSBP1 levelsGCST9046948184.98
10Mean corpuscular volume | Blood countUKBB0000044981.10
11white blood cell count (WBC, maximum, inv-norm transformed)GCST9047645180.58
12mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547479.38
13Mean corpuscular hemoglobinGCST9000239078.97
14mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547078.89
15Bursitis (PheCode 726.3)GCST9047624077.97
16Platelet crit (UKB data field 30090)GCST9046809677.85
17SEMA4D/TREML2 ratioGCST9031582377.31
18FLT3LG levelsGCST9046925076.07
19Mean corpuscular haemoglobin (UKB data field 30050)GCST9046808475.82
20EDAR/SDC4 ratioGCST9031458575.57
21mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST9047545474.70
22Platelet distribution widthGCST9000240173.84
23platelet count (maximum, inv-norm transformed)GCST9047629673.64
24mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546673.45
25Platelet distribution width (UKB data field 30110)GCST9046809773.04
26CPXM1/VEGFC ratioGCST9031422372.14
27DNM3 levelsGCST9046902272.00
28DKK1/SDC4 ratioGCST9031447971.90
29Mean corpuscular hemoglobinGCST00463071.58
30Mean corpuscular volumeGCST9000239270.81
31Mean reticulocyte volume | Blood countUKBB0000045169.98
32Platelet crit | Blood countUKBB0000064769.23
33Platelet count (UKB data field 30080)GCST9046809568.98
34DKK1/PDGFA ratioGCST9031447568.89
35ITGB1BP2/PTPN6 ratioGCST9031521868.81
36Platelet count during first trimester of pregnancyGCST9030222468.77
37CD244/EDAR ratioGCST9031376468.67
38MMP1/MMP3 ratioGCST9031546167.99
39EDAR/TNFSF12 ratioGCST9031459167.93
40PlateletcritGCST9000240067.26
41Platelet distribution width | Blood countUKBB0000064867.00
42Mean corpuscular volumeGCST00460265.81
43mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST9047545865.47
44Mean reticulocyte volumeGCST9000239664.59
45MMP1 levelsGCST9046991964.48
46Platelet distribution widthGCST00461664.20
47CCL28/PDGFB ratioGCST9031369564.19
48Mean corpuscular volume (UKB data field 30040)GCST9046808663.68
49Mean reticulocyte volume (UKB data field 30260)GCST9046808863.60
50Platelet countGCST9000240263.43
51platelet count (mean, inv-norm transformed)GCST9047629963.17
52MMP1/SERPINB6 ratioGCST9031546263.16
53Platelet count | Blood countUKBB0000064662.25
54Operation code - bunion/hallus valgus surgery | OperationsUKBB0000055162.25
55EDAR/TREML2 ratioGCST9031459262.16
56DNAJC6 levelsGCST9046901761.93
57mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST9047546261.53
58CRYGD levelsGCST9046887660.81
59sodium (minimum, inv-norm transformed)GCST9047639760.32
60TNFRSF10C levelsGCST9047090160.09
61Platelet countGCST9027864059.93
62CST3/DEFA1_DEFA1B ratioGCST9031429159.57
63PDGFA levelsGCST9047018856.15
64DKK1 levelsGCST9046899756.03
65red blood cell count (RBC, maximum, inv-norm transformed)GCST9047634555.55
66HBEGF levelsGCST9046943355.32
67Mean sphered cell volume | Blood countUKBB0000045254.54
68EDAR/SPARC ratioGCST9031458854.51
69ITGB1BP2/MED18 ratioGCST9031521354.26
70CDKN2D/ITGB1BP2 ratioGCST9031398754.23
71ENO2/ITGB1BP2 ratioGCST9031466154.16
72CPXM1/SPARC ratioGCST9031422254.03
73Low back painFING0000073053.99
74Osteoarthritis, localized (PheCode 740.1)GCST9047625453.81
75Mean corpuscular volumeGCST9000233553.62
76Prescriptions - gliclazide | sulfonylurea,diabetesUKBB0000068453.43
77KIFBP/LYN ratioGCST9031524653.42
78EDAR/PSRC1 ratioGCST9031458453.27
79Biological Grandparent (paternal): Diabetes / SugarGCST9047554953.12
80Number of non-cancer illnesses (standard GWA)GCST9026729053.11
81KIFBP/TACC3 ratioGCST9031524952.87
82Red blood cell countGCST00460152.79
83CCN2/EDAR ratioGCST9031371152.79
84GALNT5 levelsGCST9046929852.73
85Red blood cell erythrocyte count (UKB data field 30010)GCST9046809852.23
86Mean sphered cell volume (UKB data field 30270)GCST9046808952.13
87PDGFA/VEGFC ratioGCST9031562251.61
88DAPP1/PMVK ratioGCST9031439651.59
89CPXM1/MDK ratioGCST9031422151.44
90VEGFA levelsGCST9047103451.42
91APP/CD40LG ratioGCST9031331951.29
92CRYBB1 levelsGCST9046887451.17
93Red blood cell countGCST9001875151.06
94Non-cancer illness code, self-reported - type 2 diabetes | Medical conditionsUKBB0000052250.88
95platelet count (minimum, inv-norm transformed)GCST9047630250.74
96Mean corpuscular volumeGCST9001874650.74
97CCL28 levelsGCST9046858050.59
98Insomnia complaintsGCST00469550.58
99CD36 levelsGCST9046862750.48
100white blood cell count (WBC, mean, inv-norm transformed)GCST9047645450.37
101PDGFB/SDC4 ratioGCST9031562649.91
102CXCL6 levelsGCST9046893349.76
103Basophil countGCST9000229349.31
104PGLYRP1 levelsGCST9047021949.11
105FADD/MGLL ratioGCST9031476848.82
106CXCL11 levelsGCST9046892448.76
107Platelet count during second trimester of pregnancyGCST9030222548.71
108Telomere length (principal component 1)GCST9043514448.43
109Red blood cell countGCST9000236448.04
110FADD/PTPN6 ratioGCST9031477547.80
111COCH levelsGCST9046881047.72
112CAPS levelsGCST9046853947.53
113PlateletcritGCST00460747.41
114MZB1 levelsGCST9046998747.25
115F2R/ITGB1BP2 ratioGCST9031473147.22
116CDKN2D/MANF ratioGCST9031398947.01
117COL2A1 levelsGCST9046881647.01
118Mean spheric corpuscular volumeGCST9000239746.40
119APP/NID1 ratioGCST9031332646.36
120SDC4/SERPINE1 ratioGCST9031581946.19
121SEMA4D levelsGCST9047057346.09
122CCN2/DKK1 ratioGCST9031371045.95
123Alcohol dependenceFING0000005045.79
124CD84/TREML2 ratioGCST9031391945.77
125HBEGF/SDC4 ratioGCST9031503745.69
126ABHD14B/APRT ratioGCST9031313745.38
127CXCL12/TIMP3 ratioGCST9031433845.04
128GRAP2/MAP4K5 ratioGCST9031498244.92
129Insomnia complaintsGCST00648844.76
130CDKN2D/TACC3 ratioGCST9031399244.33
131FUT8/PDGFA ratioGCST9031489044.28
132CCL2 levelsGCST9046858144.20
133Red blood cell countGCST9000240343.86
134Platelet countGCST00460343.28
135Lower back pain or/and sciaticaFING0000073143.17
136PIK3AP1 levelsGCST9047023343.14
137BTC levelsGCST9046847642.92
138CNTNAP2/DPP10 ratioGCST9031416742.85
139DorsalgiaFING0000047242.55
140MAX/STK24 ratioGCST9031540442.51
141Basophil countGCST9001872642.06
142SPARC/TACC3 ratioGCST9031587241.66
143Platelet count during third trimester of pregnancyGCST9030222641.65
144CLEC1B/NSFL1C ratioGCST9031409941.39
145Subclinical hypothyroidism in pregnancyGCST9043519741.29
146MAX/TDRKH ratioGCST9031540641.28
147ANGPT1/CPXM1 ratioGCST9031326240.87
148CA4/TNFSF12 ratioGCST9031358940.83
149IDP dMRI ProbtrackX ISOVF ifo lGCST9000453740.81
150Age at first sexual intercourseGCST9000004640.79
151SNAP23/ZBTB16 ratioGCST9031585840.56
152CLEC1B/RWDD1 ratioGCST9031410240.40
153Pain in limb (PheCode 773)GCST9047627040.32
154Mean corpuscular hemoglobinGCST9001874440.28
155PDGFA/SCARF1 ratioGCST9031561740.12
156CXCL3/CXCL5 ratioGCST9031434440.09
157White blood cell countGCST9001875840.00
158red blood cell count (RBC, minimum, inv-norm transformed)GCST9047635339.99
159Red blood cell (erythrocyte) count | Blood countUKBB0000074739.88
160AXIN1/MAP2K6 ratioGCST9031341339.83
161F9/RARRES2 ratioGCST9031474939.61
162Heart failure, strictFING0000060639.45
163CCL17 levelsGCST9046856939.29
164Platelet countGCST9001874939.28
165REST UKBBICA NODEamps25 0014GCST9038549739.24
166CDKN1A/TACC3 ratioGCST9031397539.23
167CPXM1/LGMN ratioGCST9031422039.21
168Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST9016527138.95
169Number of operations, self-reported | OperationsUKBB0000053938.93
170Pain (PheCode 338)GCST9047583638.65
171CCL17/GRK5 ratioGCST9031368738.44
172Prescriptions - sulfonylurea|diabetesUKBB0000070338.42
173ENO2/RWDD1 ratioGCST9031466738.36
174PPCDC/RWDD1 ratioGCST9031570438.24
175CXCL6/DFFA ratioGCST9031435738.21
176CLEC1B/VTA1 ratioGCST9031410738.20
177red blood cell count (RBC, mean, inv-norm transformed)GCST9047634938.11
178CRADD/FADD ratioGCST9031423738.08
179CCL5/TACC3 ratioGCST9031370737.95
180VEGFC levelsGCST9047103637.88
181TRIAP1 levelsGCST9047096337.87
182ANXA3/BID ratioGCST9031327937.70
183CXCL5 levelsGCST9046893237.52
184CD63/EDAR ratioGCST9031386437.42
185ATP5IF1 levelsGCST9046839237.42
186CLEC1B/LGALS8 ratioGCST9031409637.42
187CCN2/VEGFC ratioGCST9031371937.33
188Anterior diffusion tensor imaging along the perivascular space indexGCST9045554337.21
189F-caffeinated/sweet liking (derived food-liking factor)GCST9009472037.19
190DARS1 levelsGCST9046894737.12
191ARHGAP1 levelsGCST9046835237.09
192neutrophil (absolute count, maximum, inv-norm transformed)GCST9047552637.00
193AXL/CD163 ratioGCST9031341836.93
194MAP3K5/ZBTB16 ratioGCST9031538036.79
195BDNF levelsGCST9046843736.76
196GP5 levelsGCST9046938336.59
197SDC4/SELP ratioGCST9031581736.54
198Other and unspecified tonsillitisFING0000095436.39
199DAG1/F2R ratioGCST9031437435.89
200Tea difference likingGCST9009485535.79
201IPCEF1/SMAD1 ratioGCST9031518535.77
202CRELD2/F2R ratioGCST9031425435.74
203JAM3 levelsGCST9046966035.74
204Right-hemisphere default mode network to amygdala white-matter structural connectivityGCST9030284935.64
205Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST9030279735.64
206ITGB1BP2 levelsGCST9046964235.52
207Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary AdministrationUKBB0000046435.51
208ANGPT1/CCN2 ratioGCST9031326135.32
209neutrophil (absolute count, mean, inv-norm transformed)GCST9047552935.26
210Other joint disordersFING0000106435.25
211Platelet countGCST9000235835.17
212CRISP3 levelsGCST9046886635.16
213FGF2/HBEGF ratioGCST9031481135.14
214LCN2 levelsGCST9046974734.82
215CD40 levelsGCST9046863334.78
216CXCL5/SDC4 ratioGCST9031435334.77
217DEFA1 or DEFA1B levelsGCST9046897934.74
218TIMP3 levelsGCST9047087134.65
219White blood cell count (basophil)GCST00461834.63
220Sodium (mean, inv-norm transformed)GCST9047639534.55
221SMTN levelsGCST9047068934.49
222CXCL5/EDAR ratioGCST9031434934.43
223CPXM1 levelsGCST9046884934.32
224FADD/LACTB2 ratioGCST9031476734.20
225SMAD1 levelsGCST9047067534.09
226Right-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST9030279434.07
227Arthropathy NOS | musculoskeletalUKBB0000005134.05
228Basophil percentage of white cellsGCST00463133.98
229CLEC1B/SNAP29 ratioGCST9031410333.91
230ANGPT1/APP ratioGCST9031326033.90
231TGFB1 levelsGCST9047084333.82
232CYB5R2 levelsGCST9046893733.59
233TPD52L2 levelsGCST9047094233.40
234Tea with sugar likingGCST9009485733.33
235DAG1 levelsGCST9046894333.26
236CPXM1/DKK1 ratioGCST9031421833.04
237EDAR/PRDX5 ratioGCST9031458333.02
238AZU1/RNASE3 ratioGCST9031342833.00
239NUCB2/TRIAP1 ratioGCST9031557732.89
240DKK1/SERPINE1 ratioGCST9031448032.73
241PDGFB levelsGCST9047018932.67
242CXCL5/SERPINE1 ratioGCST9031435432.67
243EGFL7 levelsGCST9046908332.66
244PPP1R2/TMSB10 ratioGCST9031572132.63
245PLIN3/VSIR ratioGCST9031567932.58
246PDGFA/SPARC ratioGCST9031562032.55
247FLT3/FLT3LG ratioGCST9031485932.39
2481-linoleoyl-GPI (18:2) levelsGCST9019982132.38
249Mean platelet (thrombocyte) volume | Blood countUKBB0000045032.33
250ATP5IF1/DECR1 ratioGCST9031338232.24
251Taking other prescription medications | MedicationUKBB0000081332.21
252FCRL1/TREML2 ratioGCST9031479732.21
253Abdominal pain | symptomsUKBB0000000332.18
254Depression medicationsFING0000039931.94
255ADGRE5/SEMA7A ratioGCST9031318331.70
256Immature reticulocyte fraction | Blood countUKBB0000035531.69
257DNPH1/PDGFB ratioGCST9031452731.66
258ENO2/MGLL ratioGCST9031466331.66
259ANXA3/ENO2 ratioGCST9031328131.58
260CXCL8 levelsGCST9046893431.56
261MPI/TACC3 ratioGCST9031549131.56
262Age at first sexual intercourseGCST9000004731.52
263SERPINH1 levelsGCST9047060131.52
264SERPINB9 levelsGCST9047059331.50
265ArthropathiesFING0000010731.50
266MECR levelsGCST9046987931.49
267ABHD14B/CRADD ratioGCST9031314131.44
268TNFRSF14 levelsGCST9047090731.44
269PDGFA/SERPINE1 ratioGCST9031561831.30
270TNFRSF13C/TNFSF13B ratioGCST9031593431.29
271SCARF1 levelsGCST9047053631.28
272Mean reticulocyte volumeGCST9002597531.26
273Peak expiratory flow (PEF) | SpirometryUKBB0000063831.21
274Blood cell traits latent factor 18 (platelet)GCST9055926031.19
275CFC1 levelsGCST9046872431.17
276APP/CCL28 ratioGCST9031331731.13
277BMI and adiposity (confirmatory factor analysis Factor 7)GCST9030934231.00
278NID1/TIMP3 ratioGCST9031554330.90
279GP1BA/HBEGF ratioGCST9031495630.84
280Obstructive chronic bronchitis (PheCode 496.21)GCST9047603030.84
281Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST9006036530.82
282Other arthropathies | musculoskeletalUKBB0000060130.80
283Prescriptions - ACE inhibitor|anti-hypertensiveUKBB0000065730.74
284ATP5IF1/LYN ratioGCST9031338930.70
285SERPINE2 levelsGCST9047059730.50
286ATP5IF1/METAP1D ratioGCST9031339130.45
287LYN/YES1 ratioGCST9031535130.43
288NTF4 levelsGCST9047009530.41
289PDAP1 levelsGCST9047017930.28
290MAP2 levelsGCST9046985330.28
291SNAP29/TJAP1 ratioGCST9031586130.28
292Attention deficit hyperactivity disorderGCST9056844130.27
293Principal component-derived dietary pattern 45GCST9013305030.26
294CALCOCO1/MAP3K5 ratioGCST9031360530.24
295CXCL5/SPARC ratioGCST9031435530.19
296BAX/MAX ratioGCST9031346630.14
297ATP5IF1/HSPA1A ratioGCST9031338830.08
298Chronic diseases of tonsils and adenoidsFING0000028330.08
299PVALB levelsGCST9047039330.07
300Principal component-derived dietary pattern 2GCST9013300730.04
301Paracetamol of NSAID medicationFING0000114530.04
302Salt added to food | DietUKBB0000076229.92
303TFPI2 levelsGCST9047083829.91
304HematocritGCST9001874029.82
305HTRA2/TRIAP1 ratioGCST9031509929.79
306Gonarthrosis, primary, with knee surgeryFING0000058629.78
307DEFA1_DEFA1B/PTGDS ratioGCST9031445529.67
3081-ribosyl-imidazoleacetate levelsGCST9019981529.66
309Educational attainmentGCST00349629.62
310Immature reticulocyte fraction (UKB data field 30280)GCST9046807929.61
311CD40LG levelsGCST9046863229.54
312FHIT levelsGCST9046923829.54
313Blood cell traits latent factor 22 (white cell)GCST9055926429.34
314Alcohol use disorder, ICD-basedFING0000005229.32
315Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration)GCST9016526729.29
316Drive faster than motorway speed limit | Physical activityUKBB0000019429.29
317CCL17/PDGFB ratioGCST9031368829.19
318TREML2 levelsGCST9047096229.18
319CCL17/F2R ratioGCST9031368629.05
320Age first had sexual intercourse | Sexual factorsUKBB0000001429.05
321DNPH1/NSFL1C ratioGCST9031452629.03
322CLEC1B levelsGCST9046876829.01
323GALNT3 levelsGCST9046929728.97
324mean platelet volume (MPV, maximum, inv-norm transformed)GCST9047551728.96
325ENO2/PLXNA4 ratioGCST9031466528.95
326SNAP23/SNAP29 ratioGCST9031585528.85
327GIPC3 levelsGCST9046934828.76
328F9/FURIN ratioGCST9031474728.73
329EBAG9/TBCB ratioGCST9031456728.70
330Leisure screen timeGCST9010433928.68
331OSCAR levelsGCST9047013128.58
332In your lifetime, have you smoked a total of at least 100 cigarettes?GCST9047638728.56
333ERP29 levelsGCST9008884328.55
334IDP dMRI TBSS OD Genu of corpus callosumGCST9000440428.48
335Treatment/medication code - ramipril | MedicationsUKBB0000085628.41
336Shortness of breath (PheCode 512.7)GCST9047604028.38
337Heart failure and bmi 25plusFING0000060328.31
338CLEC1B/GP1BA ratioGCST9031409128.31
339CD84 levelsGCST9046865328.23
340MAVS/ZBTB16 ratioGCST9031540128.21
341Whole body fat free mass (UKB data field 23101)GCST9042812028.18
342ARHGAP1/SPARC ratioGCST9031334428.17
343Osteoarthrosis (PheCode 740)GCST9047625328.14
344LAT/LYN ratioGCST9031528328.12
345SELP levelsGCST9047056928.09
346PRG3 levelsGCST9047032328.08
347SPRY2 levelsGCST9047073827.97
348white blood cell count (WBC, minimum, inv-norm transformed)GCST9047645727.95
349Mean corpuscular hemoglobin concentrationGCST9000232827.92
350EDAR/F2R ratioGCST9031457727.88
351White blood cell countGCST9000237527.76
352AXIN1/GOPC ratioGCST9031340727.75
353ITGB5/VSIR ratioGCST9031523527.75
354CCN3/PGF ratioGCST9031372227.71
355ANG/RARRES2 ratioGCST9031327127.67
356Medication use (adrenergics, inhalants)GCST9001877927.62
357MPHOSPH8 levelsGCST9046993427.59
358Immature fraction of reticulocytesGCST00462827.55
359CLEC1B/PPP1R2 ratioGCST9031410127.52
360F2R/TNFRSF14 ratioGCST9031473927.44
361FHIT/PMVK ratioGCST9031482227.43
362Gestational thrombocytopeniaGCST9030223427.34
363APP/HBEGF ratioGCST9031332427.34
364CEACAM8/PGLYRP1 ratioGCST9031400327.30
365SPARC levelsGCST9047071827.30
366ERBIN/LYN ratioGCST9031469427.21
367FGFBP3 levelsGCST9046923227.20
368TOMM20 levelsGCST9047093127.15
369ENO2/SULT1A1 ratioGCST9031466927.14
370CCN2/TPP1 ratioGCST9031371827.11
371Other diseases of upper respiratory tractFING0000101227.05
372AXIN1/BACH1 ratioGCST9031340027.02
373SIGLEC8 levelsGCST9047063627.02
374Mean platelet volumeGCST9000239526.96
375SERPINB6 levelsGCST9047059126.92
376Crohn's diseaseGCST9044679326.92
377CXCL10/CXCL11 ratioGCST9031433026.87
378monocyte (absolute count, maximum, inv-norm transformed)GCST9047549926.86
379Mean corpuscular hemoglobinGCST9000232326.83
380Hypothyroidism, drug reimbursementFING0000065526.81
381MED18/TACC3 ratioGCST9031541426.74
382CXCL5/PPIB ratioGCST9031435226.72
383NID1/SORT1 ratioGCST9031554226.70
384Nonspecific chest pain (PheCode 418)GCST9047594726.69
385EBAG9/EDAR ratioGCST9031456326.67
386CERT/MAX ratioGCST9031402826.62
387SRC/TBL1X ratioGCST9031588426.61
388APP/DAG1 ratioGCST9031332026.57
389Non-ischemic cardiomyopathyFING0000087326.48
390Sleep apnoeaFING0000130926.45
391HTRA2/SNAP29 ratioGCST9031509826.37
392APP levelsGCST9046834426.34
393Vanillylmandelate (VMA) levelsGCST9020030926.28
394Pulmonary heart disease (PheCode 415)GCST9047594226.26
395MGLL levelsGCST9046990126.23
396Mean platelet volume during second trimester of pregnancyGCST9030223026.15
397Preterm labour and deliveryFING0000120926.10
398GALNT10/TNFSF12 ratioGCST9031491626.07
399EDAR/F11R ratioGCST9031457626.04
400MDK levelsGCST9046987725.98
401LYN/TACC3 ratioGCST9031535025.95
402Mean platelet volumeGCST00459925.95
403PDGFB/SPINT2 ratioGCST9031562925.88
404Mean platelet volume during first trimester of pregnancyGCST9030222925.87
405NID2 levelsGCST9047004825.83
406SELL levelsGCST9047056725.81
407SPINT2 levelsGCST9047072825.76
408Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T216ECGA00021625.64
409Other symptoms of respiratory system (PheCode 512)GCST9047603925.63
410EBAG9/MITD1 ratioGCST9031456625.61
411Blood cell traits latent factor 8 (white cell)GCST9055925025.60
412SERPINI1 levelsGCST9047060225.59
413MCFD2/VSIR ratioGCST9031541125.53
414Codeine or tramadol medicationFING0000031125.52
415METAP1D/VASH1 ratioGCST9031542925.51
416Pain in joint (PheCode 745)GCST9047626225.47
417PLCB2 levelsGCST9047025525.44
418FABP5/PPCDC ratioGCST9031476325.44
419Types of transport used (excluding work) - Public transport | Physical activityUKBB0000087825.42
420CEACAM8/RNASE3 ratioGCST9031400425.39
421IDP dMRI ProbtrackX ISOVF ifo rGCST9000453825.34
422MATN3 levelsGCST9046986525.34
423SLAMF8 levelsGCST9047065225.28
424GOLGA3 levelsGCST9046937525.28
425Own or rent accommodation lived in - Rent - from local authority, local council, housing association | HouseholdUKBB0000062425.24
426SERPINE1 levelsGCST9047059625.22
427BMP6 levelsGCST9046845425.17
428White blood cell (leukocyte) count | Blood countUKBB0000091325.16
429SpondylosisFING0000132725.05
430FGF2 levelsGCST9046922425.04
431LCN2/S100A12 ratioGCST9031530924.96
432CCL5 levelsGCST9046858424.88
433KIF22 levelsGCST9046968224.85
434ALDH1A1/CA3 ratioGCST9031324424.85
435TNFSF12 levelsGCST9047091924.84
436Qualifications - None of the above | EducationUKBB0000072924.81
437Mean platelet thrombocyte volume (UKB data field 30100)GCST9046808724.79
438Lupus erythematosusFING0000073924.76
439S100A11/S100A12 ratioGCST9031579824.72
440red cell diameter width (RDW, minimum, inv-norm transformed)GCST9047636524.72
441CTF1/ITGB1BP2 ratioGCST9031430524.70
442Prostate cancerGCST9027471624.70
443Hypertension | circulatory systemUKBB0000033424.65
444Ankle spacing width (left) | Bone-densitometry of heelUKBB0000003324.64
445Monocyte countGCST9001874724.63
446Frequency of drinking alcohol | Alcohol useUKBB0000026024.61
447TP53BP1 levelsGCST9047093624.59
448TMSB10/TREML2 ratioGCST9031592324.58
449MAP4K5 levelsGCST9046985524.57
450Essential hypertension | circulatory systemUKBB0000020924.54
451PAPPA levelsGCST9047015724.53
452IDP T1 FAST ROIs L cerebellum VGCST9000256424.50
453Ectopic pregnancyFING0000048724.48
454SDC4/SEMA4D ratioGCST9031581824.45
455T1 FreeSurfer a2009s rh S temporal sup volumeGCST9038511024.43
456LZTFL1 levelsGCST9046983424.43
457Mean corpuscular hemoglobin concentrationGCST9000239124.42
458ATG4A/NSFL1C ratioGCST9031336824.38
459MAP2K6/TBL1X ratioGCST9031537824.32
460DCTD levelsGCST9046895724.31
461TIMP3/ZBTB16 ratioGCST9031592124.28
462SERPINE1/SPARC ratioGCST9031583424.26
463Central pulse pressureGCST9026738724.21
464IPCEF1 levelsGCST9046962424.12
465Nontoxic goitre/thyroid noduleFING0000088724.10
466Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)GCST9013295124.09
467DSG3/FABP9 ratioGCST9031455923.98
468PDGFB/TNFSF13 ratioGCST9031563223.95
469CLEC1B/DKK1 ratioGCST9031408823.93
470CXCL1 levelsGCST9046893023.92
471PF4 levelsGCST9047021123.86
472Ankle spacing width (right) | Bone-densitometry of heelUKBB0000003423.82
473AXL/GAS6 ratioGCST9031341923.79
474PRG2 levelsGCST9047032223.78
475FXN/TRIAP1 ratioGCST9031489923.75
476CETN3 levelsGCST9046872223.73
477NUB1/SRPK2 ratioGCST9031557323.69
478SNAP25 levelsGCST9047069123.68
479APRT/NSFL1C ratioGCST9031333723.68
480DCTN1/TRIAP1 ratioGCST9031443423.67
481PDGFB/TIMP3 ratioGCST9031563123.64
482CD84/DKK1 ratioGCST9031391123.63
483FHIT/MAX ratioGCST9031481823.63
484CSF3R levelsGCST9046888523.57
485DIPK2B levelsGCST9046899623.54
486PEAR1/SCARF1 ratioGCST9031564223.54
487CD40/TIMP3 ratioGCST9031382923.54
488ITPR1 levelsGCST9046965523.48
489ANGPT1 levelsGCST9046830023.38
490BSG/IL12A_IL12B ratioGCST9031353223.38
491DLL1/TGFBR2 ratioGCST9031449923.36
492Plasma X-24947 levels in chronic kidney diseaseGCST9026681623.29
493NOTCH1/SEMA7A ratioGCST9031554523.28
494Plasma 3-hydroxybutyroylglycine** levels in chronic kidney diseaseGCST9026448823.26
495Mineral and other dietary supplements - Calcium | MedicationUKBB0000047123.26
496PSRC1 levelsGCST9047036523.16
497Snoring | SleepUKBB0000078423.15
498CD40LG/EDAR ratioGCST9031381823.11
499Neutrophil percentage of white cellsGCST9000239923.08
500Blood cell traits latent factor 2 (red cell)GCST9055924423.03
501OTUD7B levelsGCST9047013723.01
502TMSB10/TXNRD1 ratioGCST9031592522.98
503Basophil percentage of granulocytesGCST00463422.97
504Participation in an health questionnaire (not invited vs invited)GCST9001279422.95
505MTSS2 levelsGCST9046996122.95
506Pain in jointFING0000113722.94
507DNA methylation Hannum age accelerationGCST9001428922.93
508EREG/TIMP3 ratioGCST9031470822.90
509BIRC2/CD40LG ratioGCST9031351722.89
510Red cell distribution widthGCST9002598822.82
511DDAH1 levelsGCST9046896622.82
512TREML1 levelsGCST9047096122.80
513FUT8 levelsGCST9046928122.80
514CST7 levelsGCST9046889722.79
515FUT8/TNFSF12 ratioGCST9031489422.77
516SnoringGCST00976022.73
517Frailty (Factor 2 - Unhealthy Lifestyle)GCST9062404822.67
518PRKRA levelsGCST9047033122.66
519DAB2 levelsGCST9046894222.66
520SULT1A1 levelsGCST9047078122.61
521Substance abuse (more control exclusions)FING0000134122.56
522Tonsillectomy and adenotomyFING0000136722.51
523Poultry consumptionGCST9013299622.47
524Platelet count during postpartum periodGCST9030222822.41
525FOXO1/MAP4K5 ratioGCST9031487222.39
526IRAK1/SPRY2 ratioGCST9031519622.32
527FAM13A levelsGCST9046918122.32
528ANXA4/FADD ratioGCST9031329122.32
529FADD/GRAP2 ratioGCST9031476622.28
530TIMM10 levelsGCST9047086722.24
531CXCL11/SDC4 ratioGCST9031433622.22
532NUDC levelsGCST9047010222.18
533ENO2/MANF ratioGCST9031466222.16
534CA1/CA3 ratioGCST9031357222.15
535EDAR/TMSB10 ratioGCST9031459022.13
536PPBP levelsGCST9047028922.07
537YTHDF3 levelsGCST9047109122.06
538Sleep apnoea, including avohilmoFING0000131022.05
539DKK1/VTA1 ratioGCST9031448522.04
540DYNLT1 levelsGCST9046905721.99
541IDP dMRI ProbtrackX ISOVF str lGCST9000454821.99
542TIA1 levelsGCST9047086221.98
543EGLN1/PIK3AP1 ratioGCST9031461921.97
544Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB0000089821.89
545Sedentary behavior at workGCST9010434521.89
546Osteoarthrosis, localized, primary (PheCode 740.11)GCST9047625521.88
547Time spent watching television (TV) | Physical activityUKBB0000082121.84
548RRM2B levelsGCST9047050021.80
549PDGFB/UXS1 ratioGCST9031563421.76
550BCR/VASH1 ratioGCST9031349921.73
551FUT3_FUT5/LILRA2 ratioGCST9031488921.69
552ADAMTS4 levelsGCST9046822621.67
553DAAM1 levelsGCST9046894121.64
554Monocyte countGCST9000234121.63
555ENO2/SCRN1 ratioGCST9031466821.62
556White blood cell countGCST00461021.61
557CLEC1B/LBR ratioGCST9031409521.60
558Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | MedicationUKBB0000045821.60
559S100A4 levelsGCST9047051821.49
560IDP dMRI ProbtrackX L1 slf rGCST9000426821.49
561Leg fat percentage right (UKB data field 23111)GCST9046817521.47
562DTD1 levelsGCST9046904521.44
563EDAR/EGF ratioGCST9031457321.42
564Biological Mother: Cancer, SkinGCST9047548721.42
565Vitamin and mineral supplements - None of the above | MedicationUKBB0000090121.39
566RILPL2 levelsGCST9047047021.39
567IL15/NCR1 ratioGCST9031515021.39
568TACC3/TRIAP1 ratioGCST9031590121.38
569SPINT2/TNFSF13 ratioGCST9031587921.38
570CD69/EDAR ratioGCST9031387521.37
571PDLIM7 levelsGCST9047019821.37
572Sleep apnea syndromeGCST9026736121.35
573Immature fraction of reticulocytesGCST9000238721.32
574MGLL/PTPN6 ratioGCST9031544021.26
575Types of transport used (excluding work) - Walk | Physical activityUKBB0000087921.25
576Lymphocyte percentage of white cellsGCST9000238921.23
577GP1BA levelsGCST9046938021.22
578AXIN1/DOK2 ratioGCST9031340621.21
579Conditional arithmetic | Fluid intelligence / reasoningUKBB0000014521.12
580Mental and behavioural disorders due to use of other stimulants, including caffeineFING0000081121.12
581METAP1D/PLXNA4 ratioGCST9031542721.10
582LAT2/YES1 ratioGCST9031528221.10
583Number of sexual partners in opposite-sex sexual behaviorGCST9002648021.08
584WASF1 levelsGCST9047106721.06
585Spleen volumeGCST9001666721.06
586CCL5/CXCL3 ratioGCST9031370021.05
587CTF1 levelsGCST9046890121.05
588APRT/EREG ratioGCST9031333520.99
589GFER/VASH1 ratioGCST9031492220.98
590HCLS1/TMSB10 ratioGCST9031504320.96
591MPIG6B levelsGCST9046993520.96
592CRADD/EDAR ratioGCST9031423520.93
593CEP20 levelsGCST9046871220.91
594CD302/IL12A_IL12B ratioGCST9031380620.89
595Current SmokerFING0000037120.87
596DAB2/GRAP2 ratioGCST9031436420.87
597Waist circumference (UKB data field 48)GCST9046818220.86
598Diffuse idiopathic skeletal hyperostosis flow scoreGCST9013453220.85
599GZMA/IL12A_IL12B ratioGCST9031500920.80
600ACOX1/VSIR ratioGCST9031315520.78
601RGS10 levelsGCST9047046520.77
602SEPTIN8 levelsGCST9047057820.76
603EIF4B levelsGCST9046909420.75
604Severe, life-threatening illness (confirmatory factor analysis Factor 20)GCST9030935420.74
605CASP10 levelsGCST9046854220.70
606SMAD3 levelsGCST9047067720.68
607Alcohol usually taken with meals | AlcoholUKBB0000002520.64
608AXIN1/INPPL1 ratioGCST9031341020.63
609CEACAM6 levelsGCST9046869720.61
610CA4/SELE ratioGCST9031358720.61
611APRT/MIF ratioGCST9031333620.60
612Blood cell traits latent factor 10 (platelet)GCST9055925220.59
613IDP dMRI TBSS ISOVF Anterior corona radiata LGCST9000450020.57
614ANGPT1/PDGFA ratioGCST9031326620.56
615IL2RA/NCR1 ratioGCST9031516120.56
616FKBP4 levelsGCST9046924320.54
617aparc-a2009s lh area S-temporal-supGCST9000336920.52
618Alcohol consumptionGCST9013300320.51
619NUCB2 levelsGCST9047010120.49
620Basophil countGCST9000229220.47
621Principal component-derived dietary pattern 8GCST9013301320.40
622Prescriptions - metformin | biguanides,diabetesUKBB0000069220.40
623SH2D1A levelsGCST9047061720.40
624Prescriptions - biguanides|diabetesUKBB0000067120.39
625BIN2/PDLIM7 ratioGCST9031350920.38
626rfMRI connectivity (ICA100 edge 995)GCST9000584820.33
627neutrophil (absolute count, minimum, inv-norm transformed)GCST9047553220.33
628ARHGEF1 levelsGCST9046835920.24
629Basophil countGCST9002599720.23
630NCK2 levelsGCST9047000720.21
631HematocritGCST9000230520.20
632GMFG levelsGCST9046936620.20
633FKBP1B levelsGCST9046924220.19
634CD40/CRELD2 ratioGCST9031381120.18
635Other embolism and thrombosisFING0000104320.16
636ACADSB levelsGCST9046819520.16
637IDP dMRI ProbtrackX ICVF str rGCST9000439920.15
638T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST9032057920.11
639Other arthrosisFING0000096520.10
640NUDT5 levelsGCST9047010720.10
641Blood cell traits latent factor 5 (platelet)GCST9055924720.05
642CASP3/MESD ratioGCST9031363620.04
643ZFYVE19 levelsGCST9047109820.00
644Right-hemisphere somatomotor network to putamen white-matter structural connectivityGCST9030279619.98
645EBI3_IL27/VCAM1 ratioGCST9031457219.97
646Leg predicted mass (left) | Impedance measuresUKBB0000039619.96
647CD84/DAG1 ratioGCST9031391019.95
648MED18/SMAD1 ratioGCST9031541319.93
649Internal derangement of knee | injuries & poisoningsUKBB0000036819.91
650AGRP/CCN1 ratioGCST9031320219.85
651LCN2/RETN ratioGCST9031530819.85
652YES1 levelsGCST9047108819.82
653Neutrophill percentage (UKB data field 30200)GCST9046809319.82
654Patient classification on admission (recoded) - Inpatient | Summary AdministrationUKBB0000063719.76
655CXCL11/CXCL13 ratioGCST9031433319.75
656Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB0000051719.72
657GonarthrosisFING0000058519.72
658KIRREL2/PLA2G1B ratioGCST9031525119.68
659TNFSF14 levelsGCST9047092219.68
660RARRES2/ST6GAL1 ratioGCST9031575919.67
661APP/VEGFC ratioGCST9031333319.67
662Leg fat-free mass (left) | Impedance measuresUKBB0000039319.67
663Number of self-reported non-cancer illnesses | Medical conditionsUKBB0000054119.66
664Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB0000036919.62
665FLT1/VEGFA ratioGCST9031485819.61
666Basophil percentage of white cellsGCST9000238019.61
667PTPRH levelsGCST9047038219.55
668FKBP14 levelsGCST9046924119.55
669AARSD1/PIK3AP1 ratioGCST9031312919.55
670Neutrophill count | Blood countUKBB0000049719.52
671TMSB10/TRIAP1 ratioGCST9031592419.49
672DNA methylation PhenoAge accelerationGCST9001429219.49
673MAP2K6 levelsGCST9046985219.47
674CEP43/WASF1 ratioGCST9031402319.42
675Nerve, nerve root and plexus disordersFING0000086219.38
676EDAR/SNAP23 ratioGCST9031458719.37
677Total diffusion tensor imaging along the perivascular space indexGCST9045554619.36
678DCTN1/ERBIN ratioGCST9031442919.34
679Leg fat-free mass (right) | Impedance measuresUKBB0000039419.34
680CIAPIN1/SNAP29 ratioGCST9031406719.30
681DKK1/VEGFA ratioGCST9031448319.25
682ESYT2 levelsGCST9046915619.24
683GHRL levelsGCST9046934119.23
684Frequency of tiredness / lethargy in last 2 weeks | Mental healthUKBB0000026819.22
685Number of days/week walked 10+ minutes | Physical activityUKBB0000053519.22
686CLEC1A/GPR37 ratioGCST9031408419.22
687CD69/CDKN2D ratioGCST9031386619.22
688F-sweetened coffee drink liking (derived food-liking factor)GCST9009485319.21
689APLP1 levelsGCST9046833019.21
690CASP2 levelsGCST9046854419.19
691FIS1 levelsGCST9046924019.18
692CD40LG/EGF ratioGCST9031381919.18
693CEP43 levelsGCST9046871519.17
694ESAM levelsGCST9046915219.15
695Principal component-derived dietary pattern 30GCST9013303519.14
696EDAR/SERPINB1 ratioGCST9031458619.14
697ENO2/TXNDC5 ratioGCST9031467119.14
698Neutrophill percentage | Blood countUKBB0000049819.13
699Monocyte count | Blood countUKBB0000047919.12
700TRIM5 levelsGCST9047097019.08
701SH2B3/TBL1X ratioGCST9031584119.05
702GOLM2 levelsGCST9046937619.04
703Ankle spacing width | Bone-densitometry of heelUKBB0000003519.03
704RAB2B levelsGCST9047040618.97
705BMP6/SPINT2 ratioGCST9031352918.96
706PRAP1 levelsGCST9047031218.87
707IMPA1 levelsGCST9046961018.83
708Operative procedures - No procedure performed | Summary OperationsUKBB0000058418.82
709Mood [affective] disordersFING0000083618.82
710Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037118.82
711Leg fat percentage (right) | Impedance measuresUKBB0000039218.79
712Leg predicted mass (right) | Impedance measuresUKBB0000039718.77
713Omega-3 fatty acids to total fatty acids percentageGCST9050246018.77
714GFER/TRIAP1 ratioGCST9031492118.76
715HNRNPK levelsGCST9046946918.75
716Sleep apnea (MTAG)GCST9026736218.68
717CIAPIN1/PLA2G4A ratioGCST9031406518.65
718F2R levelsGCST9046916818.60
719Ovarian dysfunctionFING0000113318.59
720Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST9047624618.57
721Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)GCST9013298618.57
722SNAP29/SNX9 ratioGCST9031585918.55
723Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281118.53
724Fresh fruit consumptionGCST9013297918.52
725Forced vital capacity (FVC) | SpirometryUKBB0000025418.48
726Mean platelet volume during third trimester of pregnancyGCST9030223118.48
727RGMB/TNFRSF21 ratioGCST9031577218.47
728Septal defectsFING0000129318.45
729ENO2 levelsGCST9046911018.43
730Lymphocyte percentage (UKB data field 30180)GCST9046808318.42
731DKK1/MGLL ratioGCST9031447318.41
732Age when finished full-time education (standard GWA)GCST9026728018.38
733FUT8/SORT1 ratioGCST9031489218.37
734Lymphocyte percentage | Blood countUKBB0000041218.36
735VASH1 levelsGCST9047102618.35
736Red cell distribution widthGCST9000236918.33
737Basophil countGCST9000237918.31
738Seminoma of testis, excluding all cancers (controls excluding all cancers)FING0000128918.31
739SCPEP1 levelsGCST9047055318.30
740Usual walking pace | Physical activityUKBB0000089118.29
741Deep venous thrombosisGCST9046812218.29
742EGF levelsGCST9046908618.26
743A1BG levelsGCST9046818518.25
744CXCL11/ITGB1BP2 ratioGCST9031433518.24
745Basophill percentage | Blood countUKBB0000008718.19
746LATS1 levelsGCST9046974018.19
747Volume of right cortical nucleusGCST9047491918.19
748SARG levelsGCST9047052618.18
749Migraine, single triptan purchase ok & required. ICD-code if available is includedFING0000082418.18
750POSTN levelsGCST9047028818.14
751Any mental disorderFING0000010018.13
752BLOC1S3 levelsGCST9046845018.08
753NSFL1C/PSMG3 ratioGCST9031555918.07
754Vitamin and mineral supplements - Multivitamins +/- minerals | MedicationUKBB0000090018.07
755LYN levelsGCST9046982618.05
756IGSF8/VSIR ratioGCST9031514118.05
757FKBP4/RWDD1 ratioGCST9031484018.04
758NCK2/PLA2G4A ratioGCST9031552418.01
759Treatment speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB0000083218.01
760EREG levelsGCST9046914518.01
761CST3/TIMP1 ratioGCST9031430017.98
762LCN2/PRTN3 ratioGCST9031530717.96
763CCN2/HBEGF ratioGCST9031371317.96
764COL5A1 levelsGCST9046882017.95
765AGRP/NPY ratioGCST9031320317.92
766ITGA5/SELE ratioGCST9031520517.90
767Leg fat mass (right) | Impedance measuresUKBB0000039017.89
768IL6ST/TYRO3 ratioGCST9031517017.88
769MGLL/PLA2G4A ratioGCST9031543917.88
770Follicular lymphoma, hilmo (controls excluding all cancers)FING0000054817.82
771Number of incorrect matches in round | Pairs matchingUKBB0000053817.81
772DAB2/FKBP5 ratioGCST9031436317.81
773PCDH9 levelsGCST9047017217.81
774ANXA3/ANXA4 ratioGCST9031327817.79
775PDGFA/SNAP23 ratioGCST9031561917.78
776MYDGF levelsGCST9046997217.78
777ACVRL1/TNFRSF19 ratioGCST9031315917.77
778Whole grain cereal likingGCST9009486917.77
779rfMRI connectivity ICA-features 3GCST9000634117.76
780MAVS/PPP1R9B ratioGCST9031539317.75
781BLVRB/CA1 ratioGCST9031352117.75
782Pyruvate levels (UKB data field 23472)GCST9026956917.75
783EBAG9/FKBP5 ratioGCST9031456417.74
784CD274/EFNA4 ratioGCST9031376817.73
785DFFA levelsGCST9046898717.73
786CASP3 levelsGCST9046854517.67
787Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST9030273617.65
788LGALS1 levelsGCST9046975917.65
789PEAR1/TREML2 ratioGCST9031564517.61
790Arterial embolism and thrombosis of lower extremity arteryFING0000010617.60
791Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST9004222617.59
792ADGRF5 levelsGCST9046823917.58
793CC2D1A/TMSB10 ratioGCST9031366717.56
794MTHFSD levelsGCST9046995617.55
795ANXA3/EDAR ratioGCST9031328017.55
796Chronic sinusitis (PheCode 475)GCST9047602017.52
797Acquired foot deformities (PheCode 735)GCST9047624717.51
798Red cell distribution widthGCST9000240417.50
799Red blood cell (erythrocyte) distribution width | Blood countUKBB0000074817.49
800FADD/PPP1R2 ratioGCST9031477417.49
801Alcohol drinker status - Current | AlcoholUKBB0000002117.48
802Alcohol abuse, main dg (more control exclusions)FING0000004917.47
803CCL17/CD69 ratioGCST9031368417.46
804CXCL5/MESD ratioGCST9031435017.45
805X-24337 levelsGCST9020062917.44
806CHRDL1/SMOC2 ratioGCST9031406217.44
807CD84/VASH1 ratioGCST9031392017.43
808CEP43/TIA1 ratioGCST9031402117.43
809F-healthy food liking (derived food-liking factor)GCST9009477917.41
810Tea without sugar likingGCST9009485817.39
811PHLDB1 levelsGCST9047022517.39
812FLI1 levelsGCST9046924717.39
813Annual healthcare costGCST9029260417.33
814HemoglobinGCST9001873717.32
815SIAE levelsGCST9047062917.32
816PCDH12 levelsGCST9047016817.31
817GFRA2/IL12A_IL12B ratioGCST9031492517.30
818SCARF1/TNFRSF14 ratioGCST9031581217.29
819Spicy food likingGCST9009484617.28
820DAG1/DKK1 ratioGCST9031437317.26
821FCER2/TREML2 ratioGCST9031479217.24
822Red blood cell erythrocyte distribution width (UKB data field 30070)GCST9046809917.23
823TXNDC5 levelsGCST9047099117.21
824PSTPIP2 levelsGCST9047036617.20
825FCAR levelsGCST9046919717.13
826TAB2 levelsGCST9047079617.12
827CA2/NSFL1C ratioGCST9031358017.12
828RILP/RWDD1 ratioGCST9031577817.10
829PDGFB/VEGFC ratioGCST9031563517.10
830Chronic airway obstruction (PheCode 496)GCST9047602717.09
831METAP1D levelsGCST9046989217.08
832PTPRC levelsGCST9047038017.06
833aparc-Desikan rh area isthmuscingulateGCST9000311617.06
834Acid reflux/GERDGCST9047532017.05
835EGLN1/PSIP1 ratioGCST9031462017.02
836Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB0000016717.01
837CD38/IL12A_IL12B ratioGCST9031380817.01
838Acute appendicitis, with complicationsFING0000001917.00
839CA3 levelsGCST9046851217.00
840CCN2/ENO2 ratioGCST9031371216.98
841Use of hypnotics and sedativesFING0000141116.97
842FADD/NCK2 ratioGCST9031477016.96
843EDAR/ENO2 ratioGCST9031457416.96
844CACNB3 levelsGCST9046852316.94
845MAPKAPK2 levelsGCST9046985816.92
846Bread type - White | DietUKBB0000010616.90
847Thyrotoxicosis with toxic multinodular goitreFING0000136216.89
848CA1/TGM2 ratioGCST9031357516.89
849Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST9031810816.87
850RRM2B/SMAD1 ratioGCST9031578816.87
851monocyte (absolute count, mean, inv-norm transformed)GCST9047550216.86
852CREG1/NAAA ratioGCST9031425016.84
853Average weekly beer plus cider intake | AlcoholUKBB0000008216.81
854Percentage of invited food questionnaires completedGCST9001279016.81
855DKK1/VASH1 ratioGCST9031448216.80
856red cell diameter width (RDW, maximum, inv-norm transformed)GCST9047635716.78
857Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618)GCST9013292616.77
858GADD45GIP1 levelsGCST9046929316.77
859CLEC1B/SORT1 ratioGCST9031410416.75
860Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB0000046616.74
861Frailty (Factor 1 - Limited Social Support)GCST9062404716.71
862MANF levelsGCST9046984616.70
863CD69/CLEC1B ratioGCST9031386916.70
864F-healthy breakfast food liking (derived food-liking factor)GCST9009478016.70
865aparc-a2009s rh volume S-subparietalGCST9000306916.68
866Fluid intelligence score decline (difference score)GCST9056586216.66
867IGF2R/LGMN ratioGCST9031513116.65
868ENO2/TACC3 ratioGCST9031467016.65
869THBS2 levelsGCST9047085416.62
870CMC1 levelsGCST9046879416.61
871PPP1R14D levelsGCST9047030316.61
872NT5C3A levelsGCST9047009116.61
873Prostate cancerGCST9001868516.60
874NAA80 levelsGCST9046999016.59
875CEACAM8 levelsGCST9046869816.57
876T1 CAT GM unnormalised volumeGCST9038398216.55
877Occupational attainmentGCST9010225316.55
878CD69/PLXNB3 ratioGCST9031388116.54
879Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB0000057716.51
880CD40LG/SERPINE1 ratioGCST9031382616.50
881BCL2L1 levelsGCST9046843216.49
882CCL17/THPO ratioGCST9031368916.49
883CLEC1B/DIABLO ratioGCST9031408716.48
884Medication for pain relief, constipation, heartburn - None of the above | MedicationUKBB0000045716.48
885Leg fat percentage left (UKB data field 23115)GCST9046817416.48
886ASRGL1 levelsGCST9046837916.47
887BCL2L11/VASH1 ratioGCST9031348516.47
888Waist circumference | Body size measuresUKBB0000090416.46
889aparc-a2009s rh area G-precuneusGCST9000340016.46
890Nontoxic multinodular goitreFING0000088816.45
891RAB27B levelsGCST9047040516.45
892DBNL/EDAR ratioGCST9031441616.45
893Weight | Impedance measuresUKBB0000091016.44
894ERP29 levelsGCST9046914916.44
895EREG/ITGB1BP2 ratioGCST9031470316.44
896Other diseases of intestinesFING0000100116.44
897neutrophil (fraction, minimum, inv-norm transformed)GCST9047554116.44
898F11R levelsGCST9046916416.42
899Number of treatments/medications taken | MedicationsUKBB0000054216.38
900Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB0000025116.38
901GMPR levelsGCST9046936816.38
902IDP dMRI ProbtrackX ISOVF ilf lGCST9000453916.36
903ATP5IF1/FXN ratioGCST9031338616.35
904GRAP2/PLPBP ratioGCST9031498416.32
905Lysoalkylphosphatidylcholine (O-24:0) levelsGCST9002419716.32
906CD69/CHMP1A ratioGCST9031386816.31
907CCL5/SELP ratioGCST9031370516.30
908GP6 levelsGCST9046938416.30
909METAP2 levelsGCST9046989416.28
910Enthesopathies of lower limb, excluding footFING0000050916.28
911APRT/PSME1 ratioGCST9031333816.26
912T1 FreeSurfer DK rh fusiform volumeGCST9038576316.26
913Deep vein thrombosis [DVT] (PheCode 452.2)GCST9047601016.23
914INSL4 levelsGCST9046962116.22
915Paradoxical eczema in biologic-treated plaque psoriasisGCST9016255016.21
916NFATC1 levelsGCST9047003316.18
917CD79B/ICAM3 ratioGCST9031390116.18
918White blood cell countGCST9000237416.17
919GIPC2 levelsGCST9046934716.13
920SNX9/STIP1 ratioGCST9031586416.09
921Comparative height size at age 10 | Early life factorsUKBB0000014316.09
922Frailty indexGCST9002005316.08
923PFKM levelsGCST9061880216.08
924BCAM/ICAM4 ratioGCST9031347216.07
925Substance use, excluding alcoholFING0000134216.06
926CCN2/MGLL ratioGCST9031371416.05
927IL31RA levelsGCST9046958916.05
928FUT8/VEGFC ratioGCST9031489616.03
929Forced expiratory volume (baseline)GCST9056584416.02
930CDC26 levelsGCST9046866316.01
931Essential tremor (PheCode 333.1)GCST9047583216.01
932EDAR/TACC3 ratioGCST9031458915.97
933VSTM1 levelsGCST9047105515.96
934PSME1 levelsGCST9047036015.95
935Other dyspnea (PheCode 512.9)GCST9047604215.94
936Chronic bronchitis (PheCode 496.2)GCST9047602915.90
937MED18/ZBTB16 ratioGCST9031541615.90
938ArthrosisFING0000011115.90
939CD40/TNFRSF14 ratioGCST9031383015.89
940CD38/RELT ratioGCST9031380915.88
941Irregular mensesFING0000070115.85
942Arm fat percentage (left) | Impedance measuresUKBB0000004515.84
943Red blood cell countGCST9027864115.81
944CLEC4C levelsGCST9046877215.81
945Trigger fingerFING0000137615.81
946CD22/FOLR2 ratioGCST9031375815.79
947SRPK2 levelsGCST9047074315.78
948NUDT5/TXNRD1 ratioGCST9031558215.78
949Takes medication for Diabetes/sugar?GCST9047526815.78
950Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498ECGA00049815.74
951INSL5 levelsGCST9046962215.73
952CD63 levelsGCST9046864215.72
953AXIN1/CALCOCO1 ratioGCST9031340215.72
954DRAXIN levelsGCST9046903815.72
955SNAP23 levelsGCST9047069015.70
956AARSD1/UBAC1 ratioGCST9031313515.69
957Immature fraction of reticulocytesGCST9002597115.69
958PLIN3 levelsGCST9047025915.68
959Trunk fat mass | Impedance measuresUKBB0000086315.67
960SUSD1 levelsGCST9047078615.67
961Weight | Body size measuresUKBB0000090915.64
962Other cataract | Disorders of lensUKBB0000060215.64
963LAT/SPARC ratioGCST9031528815.63
964ABHD14B/SCRN1 ratioGCST9031314515.62
965IDP dMRI ProbtrackX ISOVF ilf rGCST9000454015.59
966CASP3/SERPINE1 ratioGCST9031364315.58
967BCR/ITGB1BP2 ratioGCST9031349415.58
968FGR/LBR ratioGCST9031481415.55
969Body size (confirmatory factor analysis Factor 21)GCST9030935515.53
970BPIFB2 levelsGCST9046846315.52
971LGALS8/TXNDC5 ratioGCST9031532115.52
972Clonal hematopoiesis (DNMT3A mutation)GCST9043535415.50
973Other peripheral nerve disorders (PheCode 351)GCST9047584215.46
974CD38 levelsGCST9046862815.46
975Artrosis, including avohilmoFING0000011215.45
976Duration walking for pleasure | Physical activityUKBB0000020315.45
977NSFL1C levelsGCST9047008915.44
978Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST9030280515.44
979EDAR/TXNDC5 ratioGCST9031459315.44
980TACC3/TBC1D23 ratioGCST9031590015.42
981SNAP29/SPARC ratioGCST9031586015.42
982DAG1/HBEGF ratioGCST9031437615.42
983lymphocyte (fraction, mean, inv-norm transformed)GCST9047543515.41
984LEP levelsGCST9046975715.39
985neutrophil (fraction, mean, inv-norm transformed)GCST9047553815.39
986lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543815.39
987PPP1R2/TACC3 ratioGCST9031571915.38
988WFDC1 levelsGCST9047107415.37
989MPHOSPH8/PSRC1 ratioGCST9031547815.37
990Other and/or unspecified nontoxic goitreFING0000095815.37
991GFER levelsGCST9046932615.34
992Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activityUKBB0000087515.34
993ATP5IF1/F2R ratioGCST9031338415.33
994NAAA/SMPD1 ratioGCST9031551015.33
995MTIF3 levelsGCST9046995715.33
996Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recallUKBB0000037815.31
997OSM/TGFA ratioGCST9031559015.29
998Right-hemisphere somatomotor network to hippocampus white-matter structural connectivityGCST9030279815.28
999Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB0000058315.28
1000Sleep apnea (MTAG) (adjusted for BMI)GCST9026736415.27